NEW YORK (GenomeWeb) – The Jackson Laboratory and Wuhan Frasergen Bioinformatics will create a cancer genomics research facility in China with the aim of developing new personalized treatments.

Under a memorandum of understanding, the companies plan to launch a facility in Wuhan, Hubei Province, which hosts a center for the Chinese Academy of Sciences, Jackson Lab said on Saturday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.